UTI in children. Quick reference guide. Issue date: August 2007. Urinary tract infection in children: diagnosis, treatment and long-term management



Similar documents
Urinary tract infection in children. Urinary tract infection in children: diagnosis, treatment and long-term management

Childhood Urinary Tract Infections

Low back pain. Quick reference guide. Issue date: May Early management of persistent non-specific low back pain

URINARY TRACT INFECTION IN CHILDREN. Yap Hui Kim, Belinda Murugasu

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Urinary Tract Infections

Pyelonephritis: Kidney Infection

Identifying and treating long-term kidney problems (chronic kidney disease)

Glaucoma. Quick reference guide. Issue date: April Diagnosis and management of chronic open angle glaucoma and ocular hypertension

Rehabilitation after critical illness

THE KIDNEY. Bulb of penis Abdominal aorta Scrotum Adrenal gland Inferior vena cava Urethra Corona glandis. Kidney. Glans penis Testicular vein

The American Academy of Pediatrics

Urinary Tract Infections

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page

URINARY TRACT INFECTION IN BABIES AND PRE-SCHOOL CHILDREN

POAC CLINICAL GUIDELINE

NHS. Percutaneous endoscopic colostomy. National Institute for Health and Clinical Excellence. Issue date: March 2006

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B. Issue date: February 2006

Have a shower, rather than a bath to avoid exposing your genitals to the chemicals in your cleaning products for too long. Always empty your bladder

Leukapheresis for inflammatory bowel disease

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Antibiotic Prophylaxis for Short-term Catheter Bladder Drainage in adults. A Systematic Review (Cochrane database August 2013)

A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections

Palm Beach Obstetrics & Gynecology, PA

URINARY TRACT INFECTIONS IN YOUNG WOMEN

Beryl Navti SEPT Pharmacy Department. 24/06/2013 Beryl Navti, Clinical Pharmacist, SEPT

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.

Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke

Title: Microbiology Urine Screening Effective date: 05/08/2013. Summary of Significant Changes at this Revision

Catheter-Associated Urinary Tract Infection (CAUTI) Event

Guidelines for Management of Renal Cancer

Urinary Tract Infection Update Kim Gibson, MD Joseph Toscano, MD

A Summary of the Guideline for the Diagnosis and Management of. Urinary Tract Infections in Long Term Care

Urinary Tract Infections in Children

Connection with other policy areas and (How does it fit/support wider early years work and partnerships)

Urinary Tract Infections

Guideline for Microalbuminuria Screening

NHS. Surgical repair of vaginal wall prolapse using mesh. National Institute for Health and Clinical Excellence. 1 Guidance.

Date: 06/06/2014 Our ref: I write in response to your request for information in relation to treatment for endometrial cancer in NHS Lothian.

Alcohol use disorders: sample chlordiazepoxide dosing regimens for use in managing alcohol withdrawal

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Appendix D- Monoclonal Gammopathy of Undetermined Significance (MGUS)

Antisocial personality disorder

Exceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Understanding and Preventing Bladder Infections in Women

Borderline personality disorder

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Riesa Gusewelle, MNSc, RN, APRN, GNP-BC. OBJECTIVES Identify early warning signs of urinary tract

Long-term urinary catheters: prevention and control of healthcare-associated infections in primary and community care

Gwen Griffith Clinical Nurse Specialist Bolton NHS foundation Trust

Primary Care Management of Male Lower Urinary Tract Symptoms. Matthew B.K. Shaw Consultant Urological Surgeon

C-Difficile Infection Control and Prevention Strategies

Urine Culture, Bacterial Summary Information Highlighted items indicate most frequently used codes.

Radiofrequency ablation of varicose veins

Avoiding Urinary Tract Infections in Patients practising Intermittent Catheterization

CARE PROCESS STEP EXPECTATIONS RATIONALE

Improving access and reducing costs of care for overactive bladder through a multidisciplinary delivery model

COMPASS Therapeutic Notes on the Management of Bacterial Urinary Tract Infections in Primary Care

Urinary Tract Infections. Clinical Scenario #1. Urinary Tract Infections. Clinical Scenario #1 : Labs

Fecal incontinence (Encopresis) It is the fecal incontinence condition observed in children with chronic constipation over 1-2 years.

Problems in Early Pregnancy

Patient information leaflet for Termination of Pregnancy (TOP) / Abortion

MATERNITY SERVICES GUIDELINE POSTPARTUM BLADDER CARE. Sandra Reading, Women s CAG Deputy Director

Requirements for Provision of Outreach Paediatric Cardiology Service

Prevention and Recognition of Obstetric Fistula Training Package. Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula

PATIENT CARE MANUAL PROCEDURE

Urinary Tract Infections

APPENDIX 5 MBCHB CURRENT LEARNING OBJECTIVES. Appendix 5 166

Teriflunomide (Aubagio) 14mg once daily tablet

Feverish illness in children Assessment and initial management in children younger than 5 years

Treatments for drug misuse

CHOC CHILDREN SUROLOGY CENTER. Constipation

Service Specification Template Department of Health, updated June 2015

Step 4: Complex and severe depression in adults

Diagnosis and Treatment of Urinary Tract Infections in Children

Blood in the Urine (Haematuria)

Nocturnal Enuresis Clinical Management Tool (CMT)

NORTH OF TYNE AND GATESHEAD GUIDELINES FOR MANAGEMENT OF COMMON UROLOGICAL CONDITIONS IN ADULTS 18 YEARS. July 2013

Protocol for Macroscopic and Microscopic Urinalysis and Investigation of Urinary Tract Infections

Bladder Health Promotion

Karen R. Waters. Advanced Nurse Practitioner and Professor Martin Johnson, University of Salford

Information for you Abortion care

Guideline for Preventing Catheter- Associated Urinary Tract Infections

Rheumatoid arthritis inadults

Drug treatments for neuropathic pain

Welcome and Instructions

NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12

Spinal Cord and Bladder Management Male: Intermittent Catheter

PROCEDURE FOR THE ASSESSMENT OF ADULTS AND CHILDREN WITH BLADDER OR BOWEL DYSFUNCTION

Botox (Botulinum Toxin) injections into the bladder

Learning Disability Acute Liaison Nurse Team

Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease

Transcription:

Issue date: August 2007 UTI in children Urinary tract infection in children: diagnosis, treatment and long-term management Developed by the National Collaborating Centre for Women s and Children s Health

About this booklet This is a quick reference guide that summarises the recommendations NICE has made to the NHS in Urinary tract infection in children: diagnosis, treatment and long-term management (NICE clinical guideline 54). Who should read this booklet? This quick reference guide is for healthcare professionals and other staff who care for infants and children with urinary tract infection (UTI). It contains what you need to know to put the guideline s recommendations into practice. Who wrote the guideline? The guideline was developed by the National Collaborating Centre for Women s and Children s Health, which is based at the Royal College of Obstetricians and Gynaecologists. The Collaborating Centre worked with a group of healthcare professionals (including consultants, GPs and nurses), patients and carers, and technical staff, who reviewed the evidence and drafted the recommendations. The recommendations were finalised after public consultation. For more information on how NICE clinical guidelines are developed, go to www.nice.org.uk Where can I get more information about the guideline on UTI in children? The NICE website has the recommendations in full, summaries of the evidence they are based on, a summary of the guideline for patients and carers, and tools to support implementation (see inside back cover for more details). National Institute for Health and Clinical Excellence MidCity Place 71 High Holborn London WC1V 6NA www.nice.org.uk ISBN 1-84629-455-X National Institute for Health and Clinical Excellence, August 2007. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of the Institute. This guidance is written in the following context This guidance represents the view of the Institute, which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. The guidance does not, however, override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Contents Contents Key priorities for implementation 4 Patient flow pathway 6 Diagnosis 7 Acute management 11 Imaging tests 12 Surgical intervention 13 Follow-up 14 Information and advice following a UTI 14 Implementation 15 Further information 15 Child-centred care Treatment and care should take into account the individual needs and preferences of children with UTI, and those of their parents and carers. Good communication is essential, supported by evidencebased information, to allow parents and carers to reach informed decisions about their child s care. Introduction UTI is a common bacterial infection causing illness in infants and children. It may be difficult to recognise UTI in children because the presenting symptoms and signs are non-specific, particularly in infants and children under 3 years. Current management, which includes imaging, prophylaxis and prolonged follow-up, has placed a heavy burden on NHS primary and secondary care resources. It is costly, based on limited evidence and is unpleasant for children and distressing for their parents or carers. The aim of this guideline is to achieve more consistent clinical practice, based on accurate diagnosis and effective management. 3

Key priorities for implementation Key priorities for implementation Infants and children presenting with unexplained fever of 38 C or higher should have a urine sample tested after 24 hours at the latest. Infants and children with symptoms and signs suggestive of urinary tract infection (UTI) should have a urine sample tested for infection. The table on page 7 is a guide to the symptoms and signs that infants and children present with. A clean catch urine sample is the recommended method for urine collection. If a clean catch urine sample is unobtainable: other non-invasive methods such as urine collection pads should be used. It is important to follow the manufacturers instructions when using urine collection pads. Cotton wool balls, gauze and sanitary towels should not be used to collect urine in infants and children. when it is not possible or practical to collect urine by non-invasive methods, catheter samples or suprapubic aspiration (SPA) should be used. before SPA is attempted, ultrasound guidance should be used to demonstrate the presence of urine in the bladder. The urine-testing strategies shown in the tables on page 8 are recommended. 1 The following risk factors for UTI and serious underlying pathology should be recorded: poor urine flow history suggesting previous UTI or confirmed previous UTI recurrent fever of uncertain origin antenatally-diagnosed renal abnormality family history of vesicoureteric reflux (VUR) or renal disease constipation dysfunctional voiding enlarged bladder abdominal mass evidence of spinal lesion poor growth high blood pressure. Infants younger than 3 months with a possible UTI should be referred immediately to the care of a paediatric specialist. Treatment should be with parenteral antibiotics in line with Feverish illness in children (NICE clinical guideline 47). 1 Assess the risk of serious illness in line with Feverish illness in children (NICE clinical guideline 47) to ensure appropriate urine tests and interpretation, both of which depend on the child s age and risk of serious illness. 4

Key priorities for implementation For infants and children 3 months or older with acute pyelonephritis/upper urinary tract infection: consider referral to a paediatric specialist treat with oral antibiotics for 7 10 days. The use of an oral antibiotic with low resistance patterns is recommended, for example cephalosporin or co-amoxiclav if oral antibiotics cannot be used, treat with an intravenous (IV) antibiotic agent such as cefotaxime or ceftriaxone for 2 4 days followed by oral antibiotics for a total duration of 10 days. For infants and children 3 months or older with cystitis/lower urinary tract infection: treat with oral antibiotics for 3 days. The choice of antibiotics should be directed by locally developed multidisciplinary guidance. Trimethoprim, nitrofurantoin, cephalosporin or amoxicillin may be suitable the parents or carers should be advised to bring the infant or child for reassessment if the infant or child is still unwell after 24 48 hours. If an alternative diagnosis is not made, a urine sample should be sent for culture to identify the presence of bacteria and determine antibiotic sensitivity if urine culture has not already been carried out. Antibiotic prophylaxis should not be routinely recommended in infants and children following first-time UTI. Infants and children who have had a UTI should be imaged as outlined in the tables on page 12. 5

Patient flow pathway Patient flow pathway Assess symptoms and signs The most common presentation in infants is an undiagnosed fever Some older children present with typical symptoms and signs of UTI Page 7 Assess the risk of serious illness in line with Feverish illness in children (NICE clinical guideline 47) Page 7 Diagnosis Management Imaging Follow-up Collect urine sample using a method suitable for the age of the infant or child Page 7 Test the urine using the method recommended according to the age of the infant or child and severity of illness Page 8 Assess symptoms and signs to identify or exclude acute pyelonephritis/upper urinary tract infection Page 10 Assess risk factors for serious underlying pathology Page 10 Provide acute management according to age group and presence or absence of acute pyelonephritis/upper urinary tract infection Page 11 Arrange imaging tests if required using age, presence of atypical illness and recurrence as criteria for choice of tests Page 12 Arrange follow up for infants and children with recurrent UTI, risk factors, atypical illness and abnormal imaging Page 14 Give children and their carers appropriate advice and information at each stage 6

Diagnosis Diagnosis Assess the symptoms and signs Consider UTI in an infant or child presenting with the following symptoms and signs. Presenting symptoms and signs in infants and children with UTI Age group Symptoms and signs Most common Least common Infants younger than Fever Poor feeding Abdominal pain 3 months Vomiting Failure to thrive Jaundice Lethargy Haematuria Irritability Offensive urine Infants and Preverbal Fever Abdominal pain Lethargy children Loin tenderness Irritability 3 months Vomiting Haematuria or older Poor feeding Offensive urine Failure to thrive Verbal Frequency Dysfunctional voiding Fever Dysuria Changes to continence Malaise Abdominal pain Vomiting Loin tenderness Haematuria Offensive urine Cloudy urine Assess the risk of serious illness Assess the child s level of illness in line with Feverish illness in children (NICE clinical guideline 47). Test urine sample in infants and children: with symptoms and signs of UTI (see table above). with unexplained fever of 38 C or higher (test urine after 24 hours at the latest). with an alternative site of infection but who remain unwell (consider urine test after 24 hours at the latest). Collecting the urine sample A clean catch urine sample is the recommended method for urine collection. If a clean catch urine sample is not possible: use other non-invasive methods such as urine collection pads. Follow the manufacturer s instructions. do not use cotton wool balls, gauze or sanitary towels. If other non-invasive methods are not possible: use a catheter sample or suprapubic aspiration (SPA). Do not delay treatment if the sample cannot be obtained and the infant or child is at high risk of serious illness. 7

Diagnosis Preserving the urine sample If the sample needs to be cultured but cannot be cultured within 4 hours of collection, either refrigerate it or preserve it with boric acid immediately (refer to the manufacturer s instructions). Urine testing strategies It is important for clinicians to use clinical criteria for their decisions in cases where urine testing does not support the clinical findings. Infants younger Refer to paediatric specialist care. than 3 months Urine sample for urgent microscopy and culture. Manage in line with Feverish illness in children (NICE clinical guideline 47). Infants and children 3 months or older but younger than 3 years Use urgent microscopy and culture to diagnose UTI Specific urinary Urine sample for urgent microscopy and culture. symptoms Start antibiotic treatment. If urgent microscopy is not available, send a urine sample for microscopy and culture, and start antibiotic treatment. Non-specific High risk of serious illness: symptoms Urgent referral to paediatric specialist care. Urine sample for urgent microscopy and culture. Manage in line with Feverish illness in children (NICE clinical guideline 47). Intermediate risk of serious illness: Consider urgent referral to a paediatric specialist as described in Feverish illness in children (NICE clinical guideline 47). When specialist paediatric referral is not required: urgent microscopy and culture should be arranged antibiotic treatment should be started if microscopy is positive when urgent microscopy is not available, dipstick testing may be used as a substitute the presence of nitrites suggests the possibility of infection and antibiotic treatment should be started. In all cases, a urine sample should be sent for microscopy and culture. Low risk of serious illness: Urine sample for microscopy and culture. Start antibiotic treatment if microscopy or culture is positive. Microscopy results Pyuria positive Pyuria negative Bacteriuria positive The infant or child should be The infant or child should be regarded as having UTI regarded as having UTI Bacteriuria negative Antibiotic treatment should be The infant or child should be started if clinically UTI regarded as not having UTI 8

Diagnosis Children 3 years Use dipstick test to diagnose UTI or older If both leukocyte Start antibiotic treatment for UTI. esterase and nitrite If high or intermediate risk of serious illness or past history of UTI, send urine are positive sample for culture. If leukocyte Start antibiotic treatment if fresh sample was tested. esterase is negative Send urine sample for culture. and nitrite is positive If leukocyte Send urine sample for microscopy and culture. esterase is positive Only start antibiotic treatment for UTI if there is good clinical evidence of UTI. and nitrite is Result may indicate infection elsewhere. negative Treat depending on results of culture. If both leukocyte Do not start treatment for UTI. esterase and nitrite Explore other causes of illness. are negative Do not send urine sample for culture unless recommended in Indications for culture. Indications for culture: diagnosis of acute pyelonephritis/upper urinary tract infection high to intermediate risk of serious illness under 3 years a single positive result for leukocyte esterase or nitrite recurrent UTI infection that does not respond to treatment within 24 48 hours clinical symptoms and dipstick tests do not correlate. 9

Diagnosis Determine location Localisation of UTI is important and is generally a clinical process (see table below). Bacteriuria and fever of 38 C or higher Bacteriuria, loin pain/tenderness and fever of less than 38 C Bacteriuria but no systemic features Acute pyelonephritis/upper urinary tract infection Acute pyelonephritis/upper urinary tract infection Cystitis/lower urinary tract infection On the rare occasions when it is not possible to localise UTI clinically, and it is important to confirm or exclude acute pyelonephritis/upper urinary tract infection, use power Doppler ultrasound or a dimercaptosuccinic acid (DMSA) scan. Record the following risk factors for UTI and serious underlying pathology: poor urine flow history suggesting, or confirmed, previous UTI recurrent fever of uncertain origin antenatally-diagnosed renal abnormality family history of vesicoureteric reflux (VUR) or renal disease constipation dysfunctional voiding enlarged bladder abdominal mass evidence of spinal lesion poor growth high blood pressure. 10

Acute management Acute management If there is a high Arrange urgent referral to a paediatric specialist in line with Feverish illness in risk of serious illness children (NICE clinical guideline 47). If the infant or child Immediately refer to a paediatric specialist. is younger than Treat with parenteral antibiotics in line with Feverish illness in children 3 months (NICE clinical guideline 47). If the infant or Consider referral to a paediatric specialist. child is 3 months or Treat with oral antibiotics for 7 10 days. Use antibiotic with low resistance pattern. older with acute If oral antibiotics cannot be used, use intravenous (IV) antibiotics for 2 4 days pyelonephritis/ followed by oral antibiotics for a total duration of 10 days. upper urinary tract infection If the infant or Treat with oral antibiotics for 3 days. child is 3 months or If the child is still unwell after 24 48 hours they should be reassessed. older with cystitis/ If no alternative diagnosis, send urine for culture. lower urinary tract infection Do: use once daily dosing if an infant or child is being treated with aminoglycosides consider intramuscular treatment if parenteral treatment is required and IV treatment is not possible treat with a different antibiotic, not a higher dose of the same antibiotic, if an infant or child is receiving prophylactic medication and develops an infection laboratories should monitor resistance patterns of urinary pathogens and advise prescribers accordingly. Don t: treat asymptomatic bacteriuria with antibiotics routinely use antibiotic prophylaxis after first-time UTI but consider it after recurrent UTI. Preventing recurrence Address dysfunctional elimination syndromes and constipation. Encourage children to drink an adequate amount. Emphasise the importance of not delaying voiding. 11

Imaging tests Imaging tests Definitions Atypical UTI Recurrent UTI Seriously ill (for more information refer to Two or more episodes of UTI with acute Feverish illness in children [NICE clinical pyelonephritis/upper urinary tract infection guideline 47]) One episode of UTI with acute pyelonephritis/upper Poor urine flow urinary tract infection plus one or more episode of UTI Abdominal or bladder mass with cystitis/lower urinary tract infection Raised creatinine Three or more episodes of UTI with cystitis/lower urinary Septicaemia tract infection Failure to respond to treatment with suitable antibiotics within 48 hours Infection with non-e. coli organisms Infants and children who have had a UTI should be imaged as outlined in the tables below. Recommended imaging schedule for infants younger than 6 months Test Responds well to Atypical UTI a Recurrent UTI a treatment within 48 hours Ultrasound during the acute infection No Yes c Yes Ultrasound within 6 weeks Yes b No No DMSA 4 6 months following the acute infection No Yes Yes MCUG No Yes Yes a See box for definitions b If abnormal consider MCUG c In an infant or child with a non-e. coli-uti, responding well to antibiotics and with no other features of atypical infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks 12

Imaging tests Recommended imaging schedule for infants and children 6 months or older but younger than 3 years Test Responds well to Atypical UTI a Recurrent UTI a treatment within 48 hours Ultrasound during the acute infection No Yes c No Ultrasound within 6 weeks No No Yes DMSA 4 6 months following the acute infection No Yes Yes MCUG No No b No b a See box for definitions b While MCUG should not be performed routinely it should be considered if the following features are present: dilatation on ultrasound poor urine flow non-e. coli-infection family history of VUR. c In an infant or child with a non-e. coli-uti, responding well to antibiotics and with no other features of atypical infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks Recommended imaging schedule for children 3 years or older Test Responds well to Atypical UTI a Recurrent UTI a treatment within 48 hours Ultrasound during the acute infection No Yes b c No Ultrasound within 6 weeks No No Yes b DMSA 4 6 months following the acute infection No No Yes MCUG No No No a See box for definitions b Ultrasound in toilet-trained children should be performed with a full bladder with an estimate of bladder volume before and after micturition c In a child with a non-e. coli-uti, responding well to antibiotics and with no other features of atypical infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks If the infant or child has a subsequent UTI while awaiting DMSA, review the timing of the DMSA and consider doing it sooner. When a micturating cystourethrogram (MCUG) is performed, give oral prophylactic antibiotics for 3 days with MCUG taking place on the second day. Surgical intervention Surgical management of VUR is not routinely recommended. 13

Follow-up Follow-up Agree how to communicate the results of imaging tests with the parents or carers (or young person if appropriate). No follow-up Infants and children who do not undergo imaging investigations should not routinely be followed up. When results are normal, a follow-up outpatient appointment is not routinely required. Inform parents or carers of the results of all the investigations in writing. Infants and children who are asymptomatic following an episode of UTI should not routinely have their urine re-tested for infection. Asymptomatic bacteriuria is not an indication for follow-up. Referral and assessment Infants and children who have recurrent UTI or abnormal imaging results should be assessed by a paediatric specialist. Assessment of infants and children with renal parenchymal defects should include height, weight, blood pressure and routine testing for proteinuria. Infants and children with a minor, unilateral renal parenchymal defect do not need long-term follow-up unless they have recurrent UTI or family history or lifestyle risk factors for hypertension. Long-term follow-up Infants and children who have bilateral renal abnormalities, impaired kidney function, raised blood pressure and/or proteinuria should receive monitoring and appropriate management by a paediatric nephrologist to slow the progression of chronic kidney disease. Information and advice following a UTI Give children, parents and carers information and advice about the following: the need for treatment, the importance of completing treatment and advice about prevention and long-term management (if appropriate) the possibility of a UTI recurring, and the importance of being vigilant and seeking prompt treatment from a healthcare professional recognising symptoms quickly urine collection, storage and testing treatment prevention the nature of and reason for UTIs prognosis long-term management (if required). 14

Implementation Implementation NICE has developed tools to help organisations implement this guidance (listed below). These are available on our website (www.nice.org.uk/cg054). Slides highlighting key messages for local discussion. Implementation advice on how to put the guidance into practice and national initiatives which support this locally. Audit criteria to monitor local practice. Costing tools: costing report to estimate the national savings and costs associated with implementation costing template to estimate the local costs and savings involved. The National Collaborating Centre for Women s and Children s Health and the Guideline Development Group have also devised an algorithm. This is available on our website (www.nice.org.uk/cg054). Further information Ordering information You can download the following documents from www.nice.org.uk/cg054 A quick reference guide (this document) a summary of the recommendations for healthcare professionals. The NICE guideline all the recommendations. Understanding NICE guidance information for patients and carers. The full guideline all the recommendations, details of how they were developed, and summaries of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance, phone the NHS Response Line on 0870 1555 455 and quote: N1304 (quick reference guide) N1305 ( Understanding NICE guidance ). Related NICE guidance For information about NICE guidance that has been issued or is in development, see the website (www.nice.org.uk). Feverish illness in children: assessment and initial management in children younger than 5 years. NICE clinical guideline 47 (2007). Available from www.nice.org.uk/cg047 Updating the guideline This guideline will be updated as needed, and information about the progress of any update will be posted on the NICE website (www.nice.org/cg054). 15

National Institute for Health and Clinical Excellence MidCity Place 71 High Holborn London WC1V 6NA www.nice.org.uk N1304 1P 70k Aug 07 ISBN 1-84629-455-X